Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy-Reference-Cited by-同舟云学术

Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy

Published:2020-02-19 Issue:9 Volume:126 Page:1837-1855
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bair Steven M.¹^ORCID,Brandstadter Joshua D.¹,Ayers Emily C.¹^ORCID,Stadtmauer Edward A.¹

Affiliation:

1. Division of Hematology‐Oncology Perelman Center for Advanced Medicine University of Pennsylvania Philadelphia Pennsylvania

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32659

Reference161 articles.

1. Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

3. National Comprehensive Cancer Network.Acute myeloid leukemia (version 2.2019). Accessed May 10 2019.https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf

4. The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

5. National Comprehensive Cancer Network.Acute lymphoblastic leukemia (version 2.2019). Accessed May 25 2019.https://www.nccn.org/professionals/physician_gls/pdf/all.pdf

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteasome and PARP1 dual-target inhibitor for multiple myeloma: Fluzoparib;Biochemistry and Biophysics Reports;2024-09

2. A Revolution in Healthcare: AI-powered Cancer Imaging;Current Cancer Therapy Reviews;2024-08-13

3. Generalization of Bernoulli polynomials to find optimal solution of fractional hematopoietic stem cells model;Physica Scripta;2024-07-11

4. Dismantle and rebuild: the importance of preparedness and self-efficacy before, during and after allogeneic haematopoietic cell transplantation;Journal of Cancer Survivorship;2024-06-03

5. BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL;American Journal of Hematology;2024-06